Nature’s Sunshine Products ( (NATR) ) has released its Q2 earnings. Here is a breakdown of the information Nature’s Sunshine Products presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nature’s Sunshine Products, Inc., a prominent player in the natural health and wellness sector, specializes in manufacturing and distributing high-quality herbal and nutritional supplements across more than 40 countries. The company is known for its commitment to quality and safety, producing most of its products in its own state-of-the-art facilities.
In its latest earnings report for the second quarter of 2025, Nature’s Sunshine reported a 4% increase in net sales, reaching $114.8 million compared to the previous year. The company also saw a significant rise in GAAP net income attributable to common shareholders, which increased to $5.3 million, or $0.28 per diluted share, up from $1.3 million, or $0.07 per diluted share, in the same quarter of the previous year.
Key financial highlights include an 8% increase in adjusted EBITDA to $11.3 million, driven by higher net sales. The company experienced growth in several regions, notably in Asia and North America, with net sales increasing by 5.4% and 4.2%, respectively. Despite challenges such as unfavorable foreign exchange impacts and increased selling, general, and administrative expenses, the company maintained a strong gross profit margin of 71.7%.
Looking ahead, Nature’s Sunshine remains optimistic about its growth prospects, with management expressing confidence in the company’s global strategy and the health of its business fundamentals. The company has revised its full-year 2025 net sales expectations to range between $460 million and $475 million, reflecting a positive outlook despite ongoing macroeconomic uncertainties.